Regulatory Science & Clinical Research: Where Do We Stand (And Where Are We Going)?
It’s no secret that the FDA has recognized for years that the clinical trial system, with some of the worst return on investment (ROI) of any industry, is broken. Read…
Read MoreSpringboard’s Dolphin Tank
August 20 | Women Founders Network RSVP
Read MoreBay Area Biopharma Statistics Workshop
Embracing Challenges and Opportunities Posed by the Covid-19 Pandemic – A showcase of Pragmatic Examples by Clinical Trial Statisticians Aug 13-14 | Virtual Symposium RSVP
Read MoreSpringboard’s Dolphin Tank
August 12 | Cyber Security with Project W RSVP OR APPLY TO PITCH HERE BY JULY 22
Read MoreCenter Of Proffesional Advancements
Next Great Innovation or Just a Cool Science Project? Aug 10 | Virtual Training Course for Medical Device, Pharmaceutical, Biotechnology, Diagnostics and Veterinary Industries led by Lucia Mokres. RSVP
Read MoreSpringBoard Enterprises
July 21 | Women’s Health Innovation Coalition Launch event RSVP
Read More5 Bad Habits The Clinical Trial Community Needs To Break ASAP
The issue of clinical trial costs, both in terms of money and time, is big, complicated, and not at all new. The article discusses key persistent root causes and calls to…
Read MoreIn a landmark decision, FDA greenlights a video game for kids with ADHD
First ever digital therapeutic, EndeavoRX, developed by Akili Interactive Labs, gets an FDA approval for treatment of children with ADHD. The game has been available for limited free use by…
Read MoreHistology-Agnostic Drug Development — Considering Issues Beyond the Tissie
*Presagia AI (OccamPoint Partner member)The landmark approvals of pembrolizumab for the treatment of patients whose tumors have high microsatellite instability and larotrectinib and entrectinib for those harbouring NTRK fusions, have marked the beginning…
Read MoreEpic’s CEO is urging hospital customers to oppose rules that would make it easier to share medical info
From sharing too little patient information to sharing too much, the battles for healthcare data ownership and patients’ rights to privacy continue to unfold. For recent examples, read further on…
Read More